Reported about 8 hours ago
In after-hours trading, Amgen's stock drops as one of its obesity drugs faces a clinical hold by the FDA, while Enphase Energy's shares rise after exceeding fourth-quarter earnings and revenue expectations. Conversely, Mondelez reports disappointing results, missing on both top and bottom lines for the latest quarter.
Source: YAHOO